Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Tanner

Showing results (411-420 of 424) with videos related to

Pageof 43
Sort By:
Human Vaccines & Immunotherapeutics|April 24, 2019
Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan AfricaYolanda Guerra Mendoza, Elodie Garric, Amanda Leach, et al.
The Lancet. Infectious Diseases|July 26, 2011
Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trialKwaku Poku Asante, Salim Abdulla, Selidji Agnandji, et al.
Malaria Journal|July 21, 2021
Incidence of Plasmodium falciparum malaria infection in 6-month to 45-year-olds on selected areas of Bioko Island, Equatorial GuineaVicente Urbano Nsue Ndong Nchama, Ali Hamad Said, Ali Mtoro, et al.
The American Journal of Tropical Medicine and Hygiene|November 18, 2020
Immunogenicity and Protective Efficacy of Radiation-Attenuated and Chemo-Attenuated PfSPZ Vaccines in Equatoguinean AdultsSaid A Jongo, Vicente Urbano, L W Preston Church, et al.
Malaria Journal|October 29, 2017
Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countriesChris Drakeley, Salim Abdulla, Selidji Todagbe Agnandji, et al.
The American Journal of Tropical Medicine and Hygiene|March 25, 2025
Assessment of Health Status and Creation of a Registry of Potential Research Participants Aged 1.5 to 50 Years on Bioko Island, Equatorial GuineaMaría Silvia Angué López Mikue, Said Abdallah Jongo, Vicente Urbano Nsue Ndong Nchama, et al.
The American Journal of Tropical Medicine and Hygiene|May 9, 2023
Safety and Immunogenicity of Radiation-Attenuated PfSPZ Vaccine in Equatoguinean Infants, Children, and AdultsSaid A Jongo, Vicente Urbano Nsue Ndong Nchama, L W Preston Church, et al.
Expert Review of Vaccines|August 12, 2023
Sporozoite immunization: innovative translational science to support the fight against malariaThomas L Richie, L W Preston Church, Tooba Murshedkar, et al.
Global Health Action|November 8, 2014
Malaria mortality in Africa and Asia: evidence from INDEPTH health and demographic surveillance system sitesP Kim Streatfield, Wasif A Khan, Abbas Bhuiya, et al.
The American Journal of Tropical Medicine and Hygiene|February 7, 2022
Multi-Dose Priming Regimens of PfSPZ Vaccine: Safety and Efficacy against Controlled Human Malaria Infection in Equatoguinean AdultsSaid Abdallah Jongo, L W Preston Church, Vicente Urbano Nsue Ndong Nchama, et al.
Pageof 43

Showing results (411-420 of 424) with videos related to

Sort By:
Pageof 43
Human Vaccines & Immunotherapeutics|April 24, 2019
Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan AfricaYolanda Guerra Mendoza, Elodie Garric, Amanda Leach, et al.
The Lancet. Infectious Diseases|July 26, 2011
Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trialKwaku Poku Asante, Salim Abdulla, Selidji Agnandji, et al.
Malaria Journal|July 21, 2021
Incidence of Plasmodium falciparum malaria infection in 6-month to 45-year-olds on selected areas of Bioko Island, Equatorial GuineaVicente Urbano Nsue Ndong Nchama, Ali Hamad Said, Ali Mtoro, et al.
The American Journal of Tropical Medicine and Hygiene|November 18, 2020
Immunogenicity and Protective Efficacy of Radiation-Attenuated and Chemo-Attenuated PfSPZ Vaccines in Equatoguinean AdultsSaid A Jongo, Vicente Urbano, L W Preston Church, et al.
Malaria Journal|October 29, 2017
Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countriesChris Drakeley, Salim Abdulla, Selidji Todagbe Agnandji, et al.
The American Journal of Tropical Medicine and Hygiene|March 25, 2025
Assessment of Health Status and Creation of a Registry of Potential Research Participants Aged 1.5 to 50 Years on Bioko Island, Equatorial GuineaMaría Silvia Angué López Mikue, Said Abdallah Jongo, Vicente Urbano Nsue Ndong Nchama, et al.
The American Journal of Tropical Medicine and Hygiene|May 9, 2023
Safety and Immunogenicity of Radiation-Attenuated PfSPZ Vaccine in Equatoguinean Infants, Children, and AdultsSaid A Jongo, Vicente Urbano Nsue Ndong Nchama, L W Preston Church, et al.
Expert Review of Vaccines|August 12, 2023
Sporozoite immunization: innovative translational science to support the fight against malariaThomas L Richie, L W Preston Church, Tooba Murshedkar, et al.
Global Health Action|November 8, 2014
Malaria mortality in Africa and Asia: evidence from INDEPTH health and demographic surveillance system sitesP Kim Streatfield, Wasif A Khan, Abbas Bhuiya, et al.
The American Journal of Tropical Medicine and Hygiene|February 7, 2022
Multi-Dose Priming Regimens of PfSPZ Vaccine: Safety and Efficacy against Controlled Human Malaria Infection in Equatoguinean AdultsSaid Abdallah Jongo, L W Preston Church, Vicente Urbano Nsue Ndong Nchama, et al.
Pageof 43